Insider Transactions in Q2 2021 at Adicet Bio, Inc. (ACET)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 16
2021
|
Chen Schor President & CEO |
SELL
Open market or private sale
|
Indirect |
16,466
-9.09%
|
$164,660
$10.53 P/Share
|
|
Jun 15
2021
|
Aya Jakobovits |
SELL
Open market or private sale
|
Indirect |
3,847
-0.88%
|
$42,317
$11.16 P/Share
|
|
Jun 04
2021
|
Francesco Galimi SVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,983
+50.0%
|
$34,915
$5.97 P/Share
|
|
Jun 03
2021
|
Chen Schor President & CEO |
SELL
Open market or private sale
|
Indirect |
16,466
-8.33%
|
$197,592
$12.06 P/Share
|
|
May 20
2021
|
Aya Jakobovits |
SELL
Open market or private sale
|
Indirect |
1,792
-0.41%
|
$25,088
$14.23 P/Share
|
|
May 19
2021
|
Chen Schor President & CEO |
SELL
Open market or private sale
|
Indirect |
16,466
-3.87%
|
$214,058
$13.58 P/Share
|
|
May 18
2021
|
Aya Jakobovits |
SELL
Open market or private sale
|
Indirect |
6,208
-1.4%
|
$86,912
$14.06 P/Share
|
|
May 12
2021
|
Aya Jakobovits |
SELL
Open market or private sale
|
Indirect |
10,000
-2.2%
|
$130,000
$13.24 P/Share
|
|
May 05
2021
|
Chen Schor President & CEO |
SELL
Open market or private sale
|
Indirect |
16,466
-3.64%
|
$230,524
$14.3 P/Share
|
|
Apr 20
2021
|
Chen Schor President & CEO |
SELL
Open market or private sale
|
Indirect |
16,466
-6.67%
|
$197,592
$12.01 P/Share
|
|
Apr 06
2021
|
Chen Schor President & CEO |
SELL
Open market or private sale
|
Indirect |
16,466
-6.25%
|
$214,058
$13.04 P/Share
|